Simplex Trading’s Kindred Biosciences KIN Stock Holding History
Bought
Maintained
Sold
Simplex Trading's KIN Position: Q1 2021 in Review
Simplex Trading sold out of Kindred Biosciences (KIN) in Q1 2021, closing a stake of 10,979 shares — an estimated $53K sold.
Simplex Trading first reported a position in KIN in Q2 2015 and held it in 5 quarters. The position peaked at $47K in Q4 2020. 84 funds tracked by Wall St. Rank hold KIN as of Q1 2021.
- Simplex Trading reported no remaining Kindred Biosciences position as of Q1 2021 after selling out during the quarter.
- Simplex Trading sold 10,979 Kindred Biosciences shares in Q1 2021, an estimated $53K.
- Simplex Trading first reported a position in Kindred Biosciences in Q2 2015 and held it in 5 quarters.
- Simplex Trading's Kindred Biosciences position peaked at $47K in Q4 2020.
- 84 funds tracked by Wall St. Rank held Kindred Biosciences as of Q1 2021.
Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.